Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


FDA Letter Dated Nov. 13 Shows FDA Petitioned to Decline Approval Of FibroGen's Roxadustat


Benzinga | Nov 18, 2020 08:47AM EST

FDA Letter Dated Nov. 13 Shows FDA Petitioned to Decline Approval Of FibroGen's Roxadustat

https://www.regulations.gov/document?D=FDA-2020-P-2193-0001






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC